Canada-based medical cannabis company Khiron Life Sciences Corp begins trading on the TSX Venture Exchange today under the “KHRN” symbol. While the company is based in Canada, its core operations are in Colombia, where they were one of the first companies to receive a medical cannabis license in the Latin American nation.
“We are pleased to be able to offer investors the opportunity to participate in the realization of our strategic and operational objectives. With the completion of this listing, our team will continue to focus on executing on our goal to expand across Latin America, a region with over 640 million people with unmet medical needs. Our patient-centric business model supported by world-class cultivation and extraction processes, brand loyalty development and a doctor education platform, positions us to become a dominant company in this region.” – Khiron President and CEO Alvaro Torres, in a press release
It’s the latest in a series of firsts for Khiron as they are the first medical cannabis producer with core operations in Colombia to list on any securities exchange globally. The firm struck a partnership with the Colombian Neurological Association to host two medical cannabis conferences and was one of the first companies to receive cultivation quotas for high-THC plants in Colombia. It has raised $17 million of equity capital over three financing rounds.